| CXSB2101028 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2021-07-26 | | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | | | view |
| CXSB2300062 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2023-06-10 | | | | | view |
| CXSB2101027 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2021-07-26 | | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | | | view |
| CXSB2200005 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2022-01-17 | | | | | view |
| CXSB2200057 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(原2) | Supplementary Application | 2022-06-30 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL1700146 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-08 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1600092 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2017-03-01 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXSL1700145 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-08 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1700200 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-03 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1600034 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2016-06-15 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1600035 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2016-06-15 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1300122 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2014-06-27 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2015-12-30 | view |
| CXSL1500068 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-07-22 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXSL1800071 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-07-20 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSL1700205 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-02-06 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | In Review | 2018-02-05 | view |
| CXSB2100008 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2021-01-29 | 上海复宏汉霖生物技术股份有限公司；上海复宏汉霖生物制药有限公司 | | In Review | 2021-01-28 | view |
| CXSL1600028 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2016-04-20 | 上海复旦张江生物医药股份有限公司 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXSL2000157 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2020-07-09 | 东莞市东阳光单抗生物药有限公司 | Dongguan Dongyangguang Monoclonal Antibody Biological Drug Co Ltd | In Review | 2020-07-07 | view |
| CXSL1800081 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-07-30 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1500044 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-05-25 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-05-19 | view |
